autologous adipose-derived mesenchymal stem cells + hyaluronic acid

**Autologous adipose-derived mesenchymal stem cells + hyaluronic acid** is a combination regenerative therapy used primarily for tissue repair, cartilage regeneration, and management of osteoarthritis and degenerative joint diseases[1][4][8]. Adipose-derived mesenchymal stem cells (AD-MSCs) are extracted from the patient's own adipose tissue, minimizing immunogenicity and rejection risks[3][5]. These cells secrete a broad range of growth factors and paracrine signals that modulate inflammation, enhance tissue repair, and stimulate the regeneration of damaged tissues[1][3][7]. Hyaluronic acid (HA), a glycosaminoglycan component of the extracellular matrix, acts as a supportive carrier that improves cell viability, promotes migration, and facilitates the differentiation and therapeutic efficacy of MSCs[2][4][6]. The combination synergistically enhances chondrogenic differentiation, proliferation, and regenerative modulation, making it especially useful for intra-articular injection therapies in musculoskeletal and articular cartilage pathologies[4][8]. The mechanism is largely cell therapy and tissue engineering, involving paracrine signalling, immunomodulation, anti-inflammatory effects, and direct support of extracellular matrix integrity.

Other names

autologous adipose-derived mesenchymal stem cells + hyaluronic acidautologous AD-MSCs + hyaluronic acidautologous adipose-derived MSCs + hyaluronic acid